WEBINAR โ€” Dec. 10, 2025 @ 11 AM ET
Integrated High-Throughput Platform for Functional Profiling of Myeloid Cells in Models of Pancreatic Cancerย 

TwinStrand Biosciences and Exact Sciences Announce Exclusive License Agreement for Duplex Sequencing Technology

SEATTLE, April 24, 2024 /PRNewswire/ —ย TwinStrand Biosciencesยฎ, the pioneer in Duplex Sequencing technology, which delivers accurate insights to researchers in applications ranging from genetic toxicology to residual cancer detection announces the successful acceptance of the standard project submission form (SPSF) by the Organization for Economic Cooperation and Development (OECD). This significant milestone will accelerate commencement of the global regulatory acceptance process for error-corrected Next Generation Sequencing (ecNGS) for mutagenesis testing.